نمونه ترجمه تخصصی پزشکی درباره سرطان سرویکس

cervix cancer

Cervix cancer is the second top prevalent cancer in women [1] so that there were 530 thousand cervix cancer patients in the world in 2008 and 270 thousand deaths were recorded in the same year due to this cancer [2]. According to the WHO, 85% of cervix cancer cases are in the developing countries [3]. It is the most important type of cancer in the south of Asia [2]. In the East of Asia, the highest onset rate is in Thailand followed by Taiwan and the lowest rate is in Japan. The highest rate of cervix cancer onset in Asia was in Pakistan and India in 2008. The lowest rate of prevalence in Asia is in the west of Asia with prevalence rate in Bahrein, Kuwait, and Jordan equal to 6, 4.5, and 3.3 per 100000 respectively [4]. Among the central Asian countries (Kazakhstan, Kirgizstan, Tajikistan, Turkmenistan, and Uzbekistan), the highest onset and mortality rates of the cancer are 19.9 and 10.9 respectively in Kazakhstan and the lowest onset and mortality rates are 5.7 and 3.2 respectively in Tajikistan. Studies have shown that the onset and mortality rates of the cancer in the central Asia are higher than the USA and Canada [5]. Cervix cancer is the most lethal cancer in countries with low-moderate income level such as Nepal [6]. It is also one of the highly prevalent cancers in women in Vietnam, Malesia, India, Philippine [7], and Iran [8]. In general, onset and mortality rates of the cancer in Asia are declining [9]. For instance, a study by Park et al. in Singapore between 1973 and 1977 and between 1998 and 2002 showed that the prevalence rate decreased from 17.6% to 10.6% [10]. Between 1999 and 2009, 0.3% decrease was recorded in prevalence rate of the cancer in Kazakhstan [11]. Madou et al. reported a decreased rate of mortality rate of cervix cancer in China and Korea [9]. Since screening chronic diseases like cervix cancer is highly important for a timely diagnosis and prevention [12], examining onset and mortality rates gives us the required insight to screen and prevent the disease. Given the higher prevalence of the disease in Asian countries and the notable difference between them, the present study is an attempt to identify the trend of changes in mortality and onset rates of cervix cancer in Asian countries.